Disclosure Panels Details Page
Melanoma Panel - Disclosures as of 07/12/2021
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Mark Albertini MD | Apeiron Biologics, Vienna, Austria Array BioPharma Inc, Boulder, CO Bristol-Myers Squibb Company Merck & Co., Inc. Nektar Therapeutics |
None | None | None | ✔ |
| Christopher Barker MD | Alpha Tau Medical Amgen Inc. Elekta EMD Serono Merck & Co., Inc. Physical Sciences Incorporated (through subcontracted funds from NIH) |
Regeneron Pharmaceuticals, Inc. | None | None | ✔ |
| Joel Baumgartner MD | None | None | None | None | ✔ |
| Marian Birkeland PhD | None | None | None | None | - |
| Genevieve Boland MD, PhD | InterVenn Biosciences Olink Proteomics Palleon Pharmaceuticals Takeda Pharmaceuticals North America, Inc. |
InterVenn Biosciences Merck & Co., Inc. Nektar Therapeutics Novartis Pharmaceuticals Corporation |
Novartis Pharmaceuticals Corporation | None | - |
| Bartosz Chmielowski MD, PhD | Advenchen Laboratories Aeglea Biotherapeutics Array Biopharma Ascentage Atreca Bristol-Myers Squibb Company Compugen Daiichi- Sankyo Co. Eli Lilly and Company EMD Serono Genentech, Inc. IDEAYA Biosciences Idera Immunocore Infinity Pharmaceuticals, Inc InstilBio Iovance Karyopharm Therapeutics Macrogenics Merck & Co., Inc. Nektar Therapeutics Neon Therapeutics Novartis Pharmaceuticals Corporation Oncosec PACT Pharma RAPT Therapeutics Replimune Tolero Pharmaceuticals Xencor |
Genentech, Inc. IDEAYA Iovance Biotherapeutics Nektar Therapeutics Oncosec |
None | None | ✔ |
| Dominick DiMaio MD | None | None | None | None | ✔ |
| Alison Durham MD | OncoSec Medical Incorporated | None | None | None | ✔ |
| Ryan Fields MD | None | None | None | None | ✔ |
| Martin Fleming MD, FACS | None | None | None | None | - |
| Anjela Galan MD | None | None | None | None | ✔ |
| Brian Gastman MD | Alkermes NIT |
Iovance | Castle Biosciences Quest Imaging |
Cutaneous Malignancies: A Surgical Perspective 1st Edition | ✔ |
| Kristina Gregory MSN, RN, OCN | None | None | None | None | - |
| Samantha Guild JD | None | Melanoma Research Program (CDMRP) State of Texas |
None | None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Ashley Holder MD | None | None | None | None | ✔ |
| John Hyngstrom MD | NA | NA | NA | NA | ✔ |
| Douglas Johnson MD, MSCI | None | None | Bristol-Myers Squibb Company Catalyst Biopharma Iovance Janssen Pharmaceutica Products, LP Merck & Co., Inc. Novartis Pharmaceuticals Corporation |
None | ✔ |
| Richard Joseph MD | Bristol-Myers Squibb Company | None | None | None | - |
| Giorgos Karakousis MD | Merck & Co., Inc. | None | None | None | ✔ |
| Ann Karosas RPh, BCOP | None | None | None | None | ✔ |
| Kari Kendra MD, PhD | Amgen Inc. Karyopharm Therapeutics Merck & Co., Inc. Pfizer Inc. Regeneron Pharmaceuticals, Inc. |
None | None | None | ✔ |
| Rashmi Kumar PhD | None | None | None | None | ✔ |
| Julie Lange MD, ScM | None | None | None | None | ✔ |
| Ryan Lanning MD, PhD | None | None | None | None | ✔ |
| Kim Margolin MD | Checkmate Pharmaceuticals IOvance |
ImaginAb Oncosec Tentarix Werewolf Xilio |
None | None | ✔ |
| Miguel Materin MD | None | Castle Biosciences | Carl Zeiss Meditec | None | - |
| Nicole McMillian MS | None | None | None | None | ✔ |
| Mai Nguyen PhD | None | None | None | None | ✔ |
| Anthony Olszanski MD, RPh | None | Bristol-Myers Squibb Company Eisai Inc. Merck & Co., Inc. Pfizer Inc. sanofi-aventis U.S. |
None | None | ✔ |
| Patrick Ott MD, PhD | AstraZeneca Pharmaceuticals LP Bristol-Myers Squibb Company Celldex Therapeutics Cytomx Genentech, Inc. Gilead Sciences, Inc. MedImmune Inc. Merck & Co., Inc. Oncorus Pfizer Inc. Xencor |
Celldex Therapeutics Merck & Co., Inc. Novartis Pharmaceuticals Corporation Roche Laboratories, Inc. |
None | None | ✔ |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Kumar Rao MD | None | None | None | None | - |
| Ramesh Rengan MD, PhD | None | AstraZeneca Pharmaceuticals LP | None | None | - |
| Merrick Ross MD | Amgen Inc. | Amgen Inc. Merck & Co., Inc. |
Amgen Inc. | None | ✔ |
| April Salama MD | Bristol-Myers Squibb Company Immunocore Merck & Co., Inc. Nektar Therapeutics |
Iovance Novartis Pharmaceuticals Corporation Pfizer Inc. Regeneron Pharmaceuticals, Inc. |
None | None | ✔ |
| Rohit Sharma MD | None | None | None | None | - |
| Joseph Skitzki MD | None | None | None | None | ✔ |
| Jeffrey Sosman MD | None | Array Bristol-Myers Squibb Company Curis Genentech, Inc. Nektar Therapeutics |
None | None | - |
| Bettyanne Sunderland BSN, RN, OCN | None | None | None | None | ✔ |
| Susan Swetter MD | None | None | None | None | ✔ |
| John Thompson MD | Calithera Pharmaceuticals | AVEO Pharmaceuticals, Inc. Iovance pharmaceuticals Regeneron Pharmaceuticals, Inc. |
None | None | ✔ |
| Katy Tsai MD | Bristol-Myers Squibb Company Genentech, Inc. Merck & Co., Inc. Novartis Pharmaceuticals Corporation Oncosec Pfizer Inc. Replimune |
Regeneron Pharmaceuticals, Inc. | Genzyme Corporation | None | ✔ |
| Evan Wuthrick MD | None | None | None | None | ✔ |